US Stock MarketDetailed Quotes

IPSEY IPSEN SA SPONS ADR EA REPR 0.25 ORD

Watchlist
  • 30.060
  • +0.530+1.79%
15min DelayClose Mar 14 16:00 ET
9.94BMarket Cap26.70P/E (TTM)

About IPSEN SA SPONS ADR EA REPR 0.25 ORD Company

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Company Profile

SymbolIPSEY
Company NameIPSEN SA SPONS ADR EA REPR 0.25 ORD
Founded1998
CEOMr. David Loew
MarketPink Market
Employees5072
Fiscal Year Ends12-31
Address65, quai Georges Gorse
CityBoulogne-Billancourt
ProvinceIle-de-France
CountryFrance
Zip Code92650
Phone33-1-58-33-50-00

Company Executives

  • Name
  • Position
  • Salary
  • David Loew
  • Director and Chief Executive Officer
  • --
  • Laetitia Ducroquet
  • Director, Deputy Chief Business Ethics Officer and Vice President, Global Business Ethics
  • --
  • Naomi Binoche
  • Director and Vice President, Strategic Alliances Management
  • --
  • Marc de Garidel
  • Chairman of the Board
  • --
  • Antoine Flochel
  • Vice Chairman of the Board
  • --
  • Philippe Bonhomme
  • Director
  • --
  • Carol Xueref
  • Director
  • --
  • Michele Ollier
  • Director
  • --
  • Anne Beaufour
  • Director
  • --
  • Henri Beaufour
  • Director
  • --
  • Karen Witts
  • Independent Director
  • --
  • Dr. Pascal Touchon, D.V.M.
  • Independent Director
  • --
  • Dr. Margaret A. Liu, M.D.
  • Independent Director
  • --
  • Dr. Piet Wigerinck, PhD
  • Independent Director
  • --

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More